Zurueck zur Suche

Reporte zur Charge UT7317JA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MN 2 WI 2 TX 2 AL 1

VAERS 2266201

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7317JA

mild
Staat
MN
Alter
40,0
Geschlecht
F
Eingang
06.05.2022
Impfdatum
28.10.2021
Beginn
19.04.2022
Tage bis Beginn
173,0
Dosis
N/A
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Fatigue Headache Myalgia Nausea Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

On 4/19/2022 I developed a sore throat about 4:30PM. The next day when I woke up I had a headache and a fever as well. I scheduled a COVID-19 test and by non on 04/20/2022 I had a positive COVID-19 result. On 04/21/2022 I had a virtual visit to discuss treatment for COVID-19. It was decided that my only option was to do the antibody infusion. I had the infusion at a different facility on 04/22/2022. When I woke up on 04/23/2022 the sore throat, fever, headache and muscle aches were gone. I did have a continuation of severe nausea for about two weeks but never threw up. I still get tired more easily than normal but other than that I feel fine now.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
COVID-19 test (04/20/2022).
Aktuelle Erkrankungen
None
Vorgeschichte
Depression/Anxiety OCD PTSD Hypertension Bipolar 1 Lactose Intolerance Organic Hypersomnia PCOS Pre Diabetes Morbid Obesity
Andere Medikamente
Vitamin C 250mg Loratadine 10mg Methylphenidate 30mg Lisinopril 20mg Propranolol 120mg Latuda 20 mg Hydrochlorothiazide 12.5mg Prenatal Vitamins Bupropion 120mg Mirena IUD
Allergien
Asenapine Lamotrigine Povidone Iodine Codeine Oxycodone Tide Detergent Seasonal Allergies
Vorherige Impfungen
-

VAERS 1854901

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7317JA

mild
Staat
WI
Alter
42,0
Geschlecht
M
Eingang
09.11.2021
Impfdatum
28.10.2021
Beginn
28.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Administration site pain Pain

Symptomtext

Patient reports soreness at vaccine administration site. Intermittent waves of pain starting around 11/4-11/5. Rated 3-9 on pain scale, described as severe ache. On 11/6, pain was rated as a nine. Patient denies taking any medication or other methods (i.e. ice, massage) to reduce pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Administration site pain
Hospital-Tage
-
Labordaten
Not at this time
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
N/A
Vorherige Impfungen
-

VAERS 1736937

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7317ja

mild
Staat
TX
Alter
8,0
Geschlecht
M
Eingang
27.09.2021
Impfdatum
24.09.2021
Beginn
24.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypersensitivity Urticaria

Symptomtext

1503: Patient returns to area, mom lifts atient?s shirt to reveal hives on back and front of trunk, neck, and on upper arms. Pt also noted to be scratching. Patient AAO, respirations even/unlabored at 20/min, patient is calm with no s/s of distress. 1505: Area cleared, Vital signs taken, initiated close monitoring and observation for safety. 1508: Administered Benadryl 25mg chewable tablet PO 1511: Language line called, explained to mother that hives are an allergic reaction, that the patient is not in immediate danger or distress, and explained the medication administered and how it should help 1517: Vital signs taken and pt reassessed. Hives still visible, but no s/s of distress or increase in severity. Close monitoring continued. 1520: Notified Dr. of situation via phone, MD orders taken: 1. Follow procedures for moderate allergic reaction 2. Continue monitoring for 30 minutes, then evaluate ensure reaction is not progressing in severity. 1524: Onsite provider NP comes to area, evaluates patient. NP reinforces that patient is experiencing a mild reaction, and that it is safe for patient to leave clinic as reaction is not progressing in severity. 1529: Patient reassessed. Fewer hives visible, and those seen are noted to be smaller and less raised. Close monitoring continued. 1537: Program manager contacted via phone and briefed on situation. 1545: Spoke with parent again via language line iinterpreter.Educated parent on hives as an allergic reaction, medication given as treatment, s/s of anaphylaxis, and instructed to seek emergency medical care if symptoms worsen. Parent verbalized understanding. 1550: Reinforced instructions to parent to seek emergency care if condition worsens. Assessment reveals hives visibly reduced, no s/s of discomfort or distress. 1551: Patient left clinic in stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
denies
Vorgeschichte
denies
Andere Medikamente
denies
Allergien
parent states pt is allergic to all meat. Parent states he eats eggs regularly and denies egg allergy.
Vorherige Impfungen
-

VAERS 1736838

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7317ja

mild
Staat
TX
Alter
10,0
Geschlecht
M
Eingang
27.09.2021
Impfdatum
24.09.2021
Beginn
24.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypersensitivity Urticaria

Symptomtext

1503: Patient returns to area, mom lifts atient?s shirt to reveal hives on back and front of trunk, neck, and on upper arms. Pt also noted to be scratching. Patient AAO, respirations even/unlabored at 20/min, child is calm with no s/s of distress. 1505: area cleared, Vital signs taken, initiated close monitoring and observation for safety. 1508: Administered Benadryl 25mg chewable tablet PO 1511: Language line called, explained to mother that hives are an allergic reaction, that the children are not in immediate danger or distress, and explained the medication administered and how it should help 1517: Vital signs taken and pt reassessed. Hives still visible, but no s/s of distress or increase in severity. Close monitoring continued. 1520: Notified Dr. of situation via phone, MD orders taken: 1. Follow SDO for moderate allergic reaction 2. Continue monitoring for 30 minutes, then evaluate ensure reaction is not progressing in severity. 1524: Onsite provider NP comes to area, evaluates patient. NP reinforces that patient is experiencing a mild reaction, and that it is safe for patient to leave clinic as reaction is not progressing in severity. 1529: Patient reassessed. Fewer hives visible, and those seen are noted to be smaller and less raised. Close monitoring continued. 1537: Program manager contacted via phone and briefed on situation. 1545: Spoke with parent again via language line iinterpreter.Educated parent on hives as an allergic reaction, medication given as treatment, s/s of anaphylaxis, and instructed to seek emergency medical care if symptoms worsen. Parent verbalized understanding. 1550: Reinforced instructions to parent to seek emergency care if condition worsens. Assessment reveals hives visibly reduced, no s/s of discomfort or distress. 1551: Patient left clinic in stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Denies
Vorgeschichte
Denies
Andere Medikamente
Denies
Allergien
parent states pt is allergic to all meat. Parent sttates he eats eggs regularly and denies egg allergy.
Vorherige Impfungen
-

VAERS 1873312

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7317JA

gering
Staat
WI
Alter
9,0
Geschlecht
M
Eingang
16.11.2021
Impfdatum
11.11.2021
Beginn
11.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Wrong product administered

Symptomtext

Client and guardian came in to clinic requesting a flu shot. Front desk staff had client's guardian complete consent form for a flu vaccine and offered VIS form. Guardian declined. Nurse brought client back into room with guardian and confirmed name and DOB. Writer confirmed they were here for a flu shot, went over screening questions and administered vaccine. After vaccine administered, client and guardian inquired that they did receive the COVID Vaccine. RN informed them that they did not receive a COVID Vaccine, that they received a flu vaccine. Client states he already had a flu vaccine. RN went over error with client and guardian and did not administer COVID Vaccine due to facility not being ready. Did refer client and guardian to other area clinic for COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
n/a
Allergien
unknown
Vorherige Impfungen
-

VAERS 1821406

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7317JA

gering
Staat
AL
Alter
33,0
Geschlecht
M
Eingang
27.10.2021
Impfdatum
19.10.2021
Beginn
19.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Computerised tomogram Corneal reflex decreased Hypoaesthesia Hypoaesthesia eye Product administered to patient of inappropriate age

Symptomtext

2 hours after vaccination started having numbness in R face, jaw and neck, R eye blinking slower than left

Weitere VAERSDATA-Felder
Praegender Schweregrund
Computerised tomogram
Hospital-Tage
-
Labordaten
CT SCAN
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
ibuprofen
Allergien
NKA
Vorherige Impfungen
-

VAERS 1768188

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7317JA

gering
Staat
MN
Alter
12,0
Geschlecht
M
Eingang
07.10.2021
Impfdatum
07.10.2021
Beginn
07.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Device connection issue Immunisation Syringe issue

Symptomtext

Vaccine leaked out at the syringe and hub connection. 2nd vaccine administered Needle-25Gx1m Lot 4155460 vaccine syringe- Lot UT7317JA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Device connection issue
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
none
Andere Medikamente
na
Allergien
NKDA
Vorherige Impfungen
-